Macrocyclic Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonists.

Macrocyclic retinoic acid receptor-related orphan receptor C2 (RORC2) inverse agonists have been designed with favorable properties for topical administration. Inspired by the unanticipated bound conformation of an acyclic sulfonamide-based RORC2 ligand from cocrystal structure analysis, macrocyclic linker connections between the halves of the molecule were explored. Further optimization of analogues was accomplished to maximize potency and refine physiochemical properties (MW, lipophilicity) best suited for topical application. Compound 14 demonstrated potent inhibition of interleukin-17A (IL-17A) production by human Th17 cells and in vitro permeation through healthy human skin achieving high total compound concentration in both skin epidermis and dermis layers.

[1]  C. Gege.  Retinoic acid-related orphan receptor gamma t (RORγt) inverse agonists/antagonists for the treatment of inflammatory diseases – where are we presently? , 2021, Expert opinion on drug discovery.

[2]  Michael Albers,et al.  Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534 , 2021, Scientific Reports.

[3]  Michael G. Yang,et al.  Azatricyclic Inverse Agonists of RORγt That Demonstrate Efficacy in Models of Rheumatoid Arthritis and Psoriasis. , 2021, ACS medicinal chemistry letters.

[4]  K. Beaumont,et al.  A phase I, randomized, double‐blind study to assess the safety, tolerability and efficacy of the topical RORC2 inverse agonist PF‐06763809 in participants with mild‐to‐moderate plaque psoriasis , 2020, Clinical and experimental dermatology.

[5]  S. Shuto,et al.  Discovery of [1,2,4]Triazolo[1,5-a]pyridine Derivatives as Potent and Orally Bioavailable RORγt Inverse Agonists. , 2020, ACS medicinal chemistry letters.

[6]  R. Pehrson,et al.  Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid‐related orphan receptor γ agonist AZD0284 , 2020, British journal of clinical pharmacology.

[7]  N. Tsuchimori,et al.  Pharmacological evaluation of TAK-828F, a novel orally available RORγt inverse agonist, on murine chronic experimental autoimmune encephalomyelitis model , 2019, Journal of Neuroimmunology.

[8]  T. Kanai,et al.  Pharmacological effects of TAK-828F: an orally available RORγt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel disease , 2019, Inflammation Research.

[9]  David C. Wood,et al.  Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist. , 2018, Journal of medicinal chemistry.

[10]  W. Wigger‐Alberti,et al.  A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK2981278 ointment in a psoriasis plaque test , 2018, The British journal of dermatology.

[11]  Mark J. Mitton-Fry,et al.  Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. , 2018, Journal of medicinal chemistry.

[12]  M. Veldhoen.  Interleukin 17 is a chief orchestrator of immunity , 2017, Nature Immunology.

[13]  2nd Inflammatory Skin Disease Summit, November 16-19, 2016, New York. , 2016, Experimental dermatology.

[14]  C. Ottmann,et al.  Identification of an allosteric binding site for RORγt inhibition , 2015, Nature Communications.

[15]  R. Grubbs,et al.  Ruthenium-based heterocyclic carbene-coordinated olefin metathesis catalysts. , 2010, Chemical reviews.

[16]  D. Littman,et al.  The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.

[17]  K. Nicolaou,et al.  Metathesis reactions in total synthesis. , 2005, Angewandte Chemie.

[18]  Jan H. van Maarseveen,et al.  Synthesis of 2-substituted piperazines via direct α-lithiation , 2005 .

[19]  B. Yang,et al.  Mild and Selective Debenzylation of Tertiary Amines Using α-Chloroethyl Chloroformate , 1993 .

[20]  T Yano,et al.  Skin permeability of various non-steroidal anti-inflammatory drugs in man. , 1986, Life sciences.